body > *:not(noscript) { display: none !important; } noscript { display: block !important; } .no-js-warning { display: flex !important; min-height: 100vh; align-items: center; justify-content: center; padding: 20px; background: #f8f9fa; text-align: center; } .no-js-card { max-width: 500px; padding: 30px; border-radius: 12px; background: white; box-shadow: 0 10px 30px rgba(0,0,0,0.08); font-family: Arial, sans-serif; } .no-js-card h1 { margin-bottom: 10px; }

JavaScript Required

JavaScript is required for this website to work correctly and provide a smooth user experience. Please enable JavaScript in your browser, then refresh the page.

Back to PharmaIndex

Evanew Vaginal Tablet

Lactobacillus Salivarius (50%) + Lactobacillus Brevis (30%) + Lactobacillus Plantarum (18.75%)

Train on this drug

Drug details

API

Lactobacillus Salivarius (50%) + Lactobacillus Brevis (30%) + Lactobacillus Plantarum (18.75%)

Drug classification

Dosage form

API strength per dosage

Dose

Mechanism of action

Indications

Bacterial infections of the vagina (bacterial vaginosis)

Side effects

No common side effects seen

Pregnancy category

Precautions

Contraindications

Interaction checker

Check interactions

Ask about possible interactions, counseling points, and safety considerations for this medicine.

Drug interaction assistant

Ask about Evanew Vaginal Tablet with another medicine, food, condition, or counseling concern.

PharmaProLearn

Excel Beyond Limits